BRNS
Price
$2.36
Change
-$0.07 (-2.88%)
Updated
May 17, 6:59 PM EST
81 days until earnings call
IMVT
Price
$30.70
Change
-$0.77 (-2.45%)
Updated
May 17, 6:59 PM EST
One day until earnings call
Ad is loading...

BRNS vs IMVT

Header iconBRNS vs IMVT Comparison
Open Charts BRNS vs IMVTBanner chart's image
Barinthus Biotherapeutics
Price$2.36
Change-$0.07 (-2.88%)
Volume$190
CapitalizationN/A
Immunovant
Price$30.70
Change-$0.77 (-2.45%)
Volume$417.99K
CapitalizationN/A
View a ticker or compare two or three
BRNS vs IMVT Comparison Chart

Loading...

BRNSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IMVTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BRNS vs. IMVT commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a StrongSell and IMVT is a Hold.

COMPARISON
Comparison
May 19, 2024
Stock price -- (BRNS: $2.35 vs. IMVT: $30.70)
Brand notoriety: BRNS and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 2% vs. IMVT: 67%
Market capitalization -- BRNS: $91.88M vs. IMVT: $4.46B
BRNS [@Biotechnology] is valued at $91.88M. IMVT’s [@Biotechnology] market capitalization is $4.46B. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, BRNS is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 4 TA indicator(s) are bullish while IMVT’s TA Score has 4 bullish TA indicator(s).

  • BRNS’s TA Score: 4 bullish, 4 bearish.
  • IMVT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BRNS is a better buy in the short-term than IMVT.

Price Growth

BRNS (@Biotechnology) experienced а +0.64% price change this week, while IMVT (@Biotechnology) price change was +4.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 08, 2024.

IMVT is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BRNS with price predictions.
OPEN
A.I.dvisor published
a Summary for IMVT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IMVT($4.46B) has a higher market cap than BRNS($91.9M). IMVT YTD gains are higher at: -27.130 vs. BRNS (-36.314).
BRNSIMVTBRNS / IMVT
Capitalization91.9M4.46B2%
EBITDAN/AN/A-
Gain YTD-36.314-27.130134%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BRNSIMVT
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
64%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
BRNSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IMVTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DAPP9.830.14
+1.44%
VanEck Digital Trfmt ETF
IEV57.920.18
+0.31%
iShares Europe ETF
MVPS21.060.01
+0.05%
Amplify Thematic All-Stars ETF
JSMD68.41-0.10
-0.14%
Janus Henderson Small/Md Cp Gr Alpha ETF
MNBD25.64-0.05
-0.18%
ALPS Intermediate Municipal Bond ETF

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-3.29%
SLNO - BRNS
56%
Loosely correlated
+1.10%
NGNE - BRNS
55%
Loosely correlated
-1.22%
BNOX - BRNS
50%
Loosely correlated
-2.22%
IMVT - BRNS
48%
Loosely correlated
-2.48%
RNAZ - BRNS
36%
Loosely correlated
+29.97%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been closely correlated with SLNO. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMVT jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-2.48%
SLNO - IMVT
79%
Closely correlated
+1.10%
ROIV - IMVT
61%
Loosely correlated
-1.58%
BRNS - IMVT
48%
Loosely correlated
-3.29%
IONS - IMVT
37%
Loosely correlated
-0.82%
AXON - IMVT
37%
Loosely correlated
-0.57%
More